Home
About Us
Blog
Contact Us

+91- 99859 25652; +91- 73863 01984 | info@sapienbio.com

About Us
Awards/Recognition
- 2020
Biobank
Products & Platforms
Diagnostics
Resources
Blog
Careers
Contact Us

You are here: Home / Blog / Blog / Job Posting for Clinical Research

Job Posting for Clinical Research

November 13, 2020/0 Comments/in Blog /by admin

Tags: biobank, ClinicalResearch, sapienbio

Share this entry

You might also like

Digital library of whole slide Images Built at Sapien

Metastatic Lung Cancer-Finding cure starts with awareness

Sapien collaborates with Dr. Anjana Rao of La Jolla Institute

Breast Cancer Protection,

Dr. Jugnu Jain shares her thoughts on entrepreneurship with the T-Hub Hyderabad

Building Genotype-Phenotype Correlation Data for Lung Cancer in India

Recurrence in Kidney Cancer

Grade and Age distribution of Brain Cancers

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Sign me up for the newsletter!

Recent Posts

Digital library of whole slide Images Built at Sapien
Dr. Jugnu Jain, CEO, delivering an invited talk on “Sustainability of Biobanking in India” at the workshop on Biobanking organized by ILBS, New Delhi.
Quatramer’s tunability stems from the fact that the system can be modified and adjusted to deliver single or multiple ratios of payloads in order to optimize synergistic mechanisms of action in lower doses.
Our paper is out in Frontiers in Pharmacology
Sapien’s work for Hillstream BioPharma presented at AACR

Recent Comments

Chinnababu Sunkavalli on The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
ashwin shah on The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
drchinnababu on Breast Cancer Protection,

Sitemap

2020
About Us
Alliance with Apollo
Awards/Recognition
- Disease Types
- Type of Samples
Biobank
Blog
Careers
Contact Us
Homepage
Jugnu Jain, a scipreneur, talks of her key skills to her success – TLOS, ICCB 2018
Our Modus Operandi
Resources

Locate Us

Sapien Biosciences,
1st Floor, AIMSR Building,
Apollo Health City,
Jubilee Hills,
Hyderabad 500 096

Phone:
+91-99859 25652
+91-73863 01984
Email:
info@sapienbio.com
queries@sapienbio.com

Recent Comments

Chinnababu Sunkavalli on The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
ashwin shah on The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
drchinnababu on Breast Cancer Protection,

Recent Posts

Digital library of whole slide Images Built at Sapien
Dr. Jugnu Jain, CEO, delivering an invited talk on “Sustainability of Biobanking in India” at the workshop on Biobanking organized by ILBS, New Delhi.
Quatramer’s tunability stems from the fact that the system can be modified and adjusted to deliver single or multiple ratios of payloads in order to optimize synergistic mechanisms of action in lower doses.
Our paper is out in Frontiers in Pharmacology
Sapien’s work for Hillstream BioPharma presented at AACR

Sign Up for our Newsletter

First Name:

Last Name:

Email Address:

Leave this field empty if you're human:

Copyright @ 2022 - All Rights Reserved - Sapien Biosciences

Home
About Us
Blog
Contact Us

Validating herbal, natural products and drug candidates in cancer patient cells... November is a Lung cancer awareness month

Scroll to top